Regencell Bioscience Holdings Limited (RGC) DCF Valuation

Regencell Bioscience Holdings Limited (RGC) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Regencell Bioscience Holdings Limited (RGC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to assess the intrinsic value of Regencell Bioscience Holdings Limited? Our (RGC) DCF Calculator merges practical data with extensive customization features, enabling you to refine your forecasts and make more informed investment choices.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -.8 -1.4 -7.0 -5.3 -3.6 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .6 .8 .7 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -.8 -1.4 -7.6 -6.1 -4.4 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .4 .1 16.4 11.6 8.0 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .2
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 -.1 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 .0 -.8 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 1.41 1.41 1.41 1.41 1.41 1.41 1.41 1.41 1.41 1.41
EBITAT -.8 -1.4 -7.4 -5.9 -4.3 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -.9 -1.3 -7.6 -5.1 -3.8 .2 .0 .0 .0 .0
WACC, % 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF .1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -3
Equity Value 3
Diluted Shares Outstanding, MM 13
Equity Value Per Share 0.23

What You Will Receive

  • Pre-Filled Financial Model: Regencell's actual data allows for accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates provide immediate feedback as you adjust inputs.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
  • Customizable and Reusable: Designed for adaptability, enabling repeated application for in-depth forecasts.

Key Features

  • Comprehensive RGC Data: Pre-filled with Regencell Bioscience Holdings Limited’s historical financials and future projections.
  • Customizable Financial Inputs: Modify key metrics such as revenue growth, profit margins, WACC, tax rates, and capital expenditures.
  • Interactive Valuation Model: Automatically recalculates Net Present Value (NPV) and intrinsic value based on user inputs.
  • Multiple Scenario Analysis: Develop various forecast scenarios to evaluate different valuation results.
  • User-Centric Interface: Intuitive, organized, and suitable for both seasoned professionals and newcomers.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Regencell Bioscience Holdings Limited’s (RGC) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly observe recalculated results, including Regencell’s intrinsic value.
  • Step 5: Make educated investment choices or create reports based on the outputs.

Why Choose This Calculator for Regencell Bioscience Holdings Limited (RGC)?

  • Designed for Experts: A specialized tool tailored for analysts, investors, and biotech consultants.
  • Accurate Data: Regencell’s historical and projected financials are preloaded for precise analysis.
  • Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and other essential metrics.
  • User-Friendly: Step-by-step guidance makes the process straightforward and accessible.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Regencell Bioscience Holdings Limited (RGC) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Regencell Bioscience Holdings Limited (RGC).
  • Consultants: Deliver professional valuation insights on Regencell Bioscience Holdings Limited (RGC) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Regencell Bioscience Holdings Limited (RGC) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Regencell Bioscience Holdings Limited (RGC).

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Regencell Bioscience Holdings Limited (RGC) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Regencell Bioscience Holdings Limited (RGC).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.